8-K
LAM RESEARCH CORP (LRCX)
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) o f the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): November 3, 2020
LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 0-12933 | 94-2634797 |
|---|---|---|
| (State or Other Jurisdiction<br>of Incorporation) | (Commission<br>File Number) | (IRS Employer<br>Identification Number) |
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510) 572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered |
|---|---|---|
| Common Stock, Par Value $0.001 Per Share | LRCX | The Nasdaq Stock Market |
| (Nasdaq Global Select Market) |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Table of Contents
Table of Contents
| Item 5.07. | Submission of Matters to a Vote of Security Holders | 3 |
|---|---|---|
| Item 8.01 | Other Events | 4 |
| Item 9.01 | Financial Statements and Exhibits | 4 |
| SIGNATURES | 5 |
Table of Contents
Item 5.07. Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders was held by webcast on November 3, 2020.
The results of voting on the following items were as set forth below:
(a)The votes for nominated directors, to serve until the next annual meeting of stockholders, and until their successors are elected and qualified, were as follows:
| NOMINEE | % OF<br><br>VOTES<br><br>CAST FOR | FOR | WITHHELD | BROKER<br><br>NON-VOTES |
|---|---|---|---|---|
| Sohail U. Ahmed | 99.83% | 113,842,978 | 190,191 | 14,193,097 |
| Timothy M. Archer | 99.84% | 113,848,789 | 184,380 | 14,193,097 |
| Eric K. Brandt | 93.23% | 106,316,172 | 7,716,997 | 14,193,097 |
| Michael R. Cannon | 99.61% | 113,586,882 | 446,287 | 14,193,097 |
| Catherine P. Lego | 96.05% | 109,532,340 | 4,500,829 | 14,193,097 |
| Bethany J. Mayer | 99.28% | 113,214,987 | 818,182 | 14,193,097 |
| Abhijit Y. Talwalkar | 90.38% | 103,065,878 | 10,967,291 | 14,193,097 |
| Lih Shyng (Rick L.) Tsai | 99.71% | 113,700,453 | 332,716 | 14,193,097 |
| Leslie F. Varon | 98.14% | 111,909,639 | 2,123,530 | 14,193,097 |
All director nominees were duly elected.
(b) The vote on a proposal to approve on an advisory basis the compensation of the named executive officers of the Company (“Say on Pay”) was as follows:
| % OF<br><br>VOTES<br><br>CAST FOR | FOR | AGAINST | ABSTAIN | BROKER<br><br>NON-VOTES | |
|---|---|---|---|---|---|
| Total Shares Voted | 94.22% | 107,451,178 | 6,407,598 | 174,393 | 14,193,097 |
The proposal was approved.
(c) The vote on a proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2021 was as follows:
| % OF<br>VOTES <br>CAST FOR | FOR | AGAINST | ABSTAIN | BROKER<br>NON-VOTES | |
|---|---|---|---|---|---|
| Total Shares Voted | 95.54% | 122,510,955 | 5,505,387 | 209,924 | — |
The appointment was ratified.
Table of Contents
Item 8.01. Other Events
On November 5, 2020 the Company issued a press release announcing a $5 billion share repurchase authorization. A copy of the press release is attached as Exhibit 99.1 to this Form 8-K. The foregoing description of the share repurchase authorization is qualified in its entirety by reference to the full text of Exhibit 99.1 incorporated by reference in this Item 8.01.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release dated November 5, 2020 announcing a $5 billion share repurchase authorization
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: | November 5, 2020 | LAM RESEARCH CORPORATION |
|---|---|---|
| (Registrant) | ||
| By: | /s/ Ava M. Hahn | |
| Ava M. Hahn | ||
| Senior Vice President, Chief Legal Officer |
Document
FOR IMMEDIATE RELEASE
Lam Research Corporation Announces $5 Billion Share Repurchase Authorization and Declares Quarterly Dividend
FREMONT, CA -- (GLOBE NEWSWIRE) – November 5, 2020 -- Lam Research Corporation (Nasdaq: LRCX) today announced that its Board of Directors approved a $5 billion share repurchase authorization and a quarterly dividend of $1.30 per share of common stock.
The company is authorized to repurchase up to $5 billion of common stock; this authorization supplements the remaining balances from any prior authorizations. Repurchases may be made through both public market and private transactions and may include the use of derivative contracts and structured share repurchase agreements. This repurchase program has no termination date and may be suspended or discontinued at any time.
The dividend payment will be made January 6, 2021 to holders of record on December 9, 2020. Future dividend payments are subject to review and approval by the Board of Directors.
About Lam Research:
Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. As a trusted, collaborative partner to the world’s leading semiconductor companies, we combine superior systems engineering capability, technology leadership, and unwavering commitment to customer success to accelerate innovation through enhanced device performance. In fact, today, nearly every advanced chip is built with Lam technology. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)
Caution Regarding Forward-Looking Statements:
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to, our plans to make dividend payments, declare dividends, or increase dividends over time, or the timing or frequency of dividend increases, our engineering capabilities, our technology leadership, our commitment to customer success, and our continued ability to accelerate innovation and enhance device performance. Some factors that may affect these forward–looking statements include: the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form
10-K for the fiscal year ended June 28, 2020 and quarterly report on Form 10-Q for the quarter ended September 27, 2020. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this press release.
Company Contacts:
Ram Ganesh
Investor Relations
(510) 572 – 1615
Email: investor.relations@lamresearch.com
Source: Lam Research Corporation###